Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Insud’s Xiromed Rivals Taytulla In US
Follows First-To Market Launch Of Monurol With CGT Designation
Nov 23 2020
•
By
Dave Wallace
Xiromed’s Gemmily Is The Latest In A Line Of Launches • Source: Shutterstock
More from Products
More from Generics Bulletin